CVS Health Corporation: Argus Research cuts target price to $105 from $114
CVS•Argus Research cut its target price for CVS Health Corporation to $105 from $114.
Related News
Ton Strategy names Oscar Suarez independent director and audit committee chair
TONX•
DHT Holdings expects Q4 average term time-charter rate of $100,200 a day
DHT•
Repay Holdings Corp: UBS raises target price to $4.75 from $4.25
RPAY•
Waters gets FDA clearance for OneFlow blood cancer tests
WAT•
Worthington Enterprises presents strategy for organic growth and margin expansion
WOR•